Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer Therapeutics
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer Therapeutics
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 13, Issue 12, Pages 12268-12286
Publisher
MDPI AG
Online
2012-09-28
DOI
10.3390/ijms131012268
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanism of action of therapeutic monoclonal antibodies: Promises and pitfalls of in vitro and in vivo assays
- (2012) Josée Golay et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence
- (2012) Antonis Valachis et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer
- (2012) Eun Kyoung Jeon et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
- (2012) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab
- (2011) D. Lenihan et al. ANNALS OF ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
- (2011) Kunal S. Taskar et al. PHARMACEUTICAL RESEARCH
- Activation of AMPK is necessary for killing cancer cells and sparing cardiac cells
- (2010) Scott A. Shell et al. CELL CYCLE
- The Vulnerability of the Heart As a Pluricellular Paracrine Organ
- (2010) Gilles W. De Keulenaer et al. CIRCULATION RESEARCH
- Pertuzumab for the treatment of ovarian cancer
- (2010) Simon P Langdon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Why do Kinase Inhibitors Cause Cardiotoxicity and What can be Done About It?
- (2010) Hui Cheng et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury
- (2009) Kevin Bersell et al. CELL
- Cardiac toxicity with anti-HER-2 therapies-what have we learned so far?
- (2009) Evandro de Azambuja et al. Targeted Oncology
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
- (2008) Ming Hui Chen et al. CIRCULATION
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute and fatal diarrhoea after erlotinib plus abdominal palliative hypofractionated radiotherapy in a metastatic non-small cell lung cancer patient: A case report
- (2008) Giovanni Silvano et al. LUNG CANCER
- Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) I. J. Dahabreh et al. ONCOLOGIST
- Drug Insight: intracellular inhibitors of HER2—clinical development of lapatinib in breast cancer
- (2008) David A Cameron et al. Nature clinical practice. Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started